Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
about
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancerA critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinomaA CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell linesCombined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerMammary Development and Breast Cancer: A Wnt PerspectiveCrosstalk of the Insulin-Like Growth Factor Receptor with the Wnt Signaling Pathway in Breast CancerActivation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumorsDNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateA network-based gene-weighting approach for pathway analysis.Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patientsHypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesisGenetic and epigenetic tumor suppressor gene silencing are distinct molecular phenotypes driven by growth promoting mutations in nonsmall cell lung cancer.Lung cancer. 9: Molecular biology of lung cancer: clinical implications.Nitric oxide: perspectives and emerging studies of a well known cytotoxinDevelopment of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.Aberrant WNT/β-catenin signaling in parathyroid carcinoma.Key signaling nodes in mammary gland development and cancer: β-catenin.Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort.Ligand-independent canonical Wnt activity in canine mammary tumor cell lines associated with aberrant LEF1 expressionAging and DNA methylation.Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity.Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progressionShared signaling pathways in normal and breast cancer stem cells.Considerations when analyzing the methylation status of PTEN tumor suppressor gene.Presence of c.3956delC mutation in familial adenomatous polyposis patients from Brazil.Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies.Analysis of molecular aberrations of Wnt pathway gladiators in colorectal cancer in the Kashmiri population.Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients.Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.Colorectal cancer: molecular mutations and polymorphisms.Epigenetic targeting in breast cancer: therapeutic impact and future direction.ER and PR signaling nodes during mammary gland development.Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotypeEpigenomics and breast cancerDNA methylation as clinically useful biomarkers-light at the end of the tunnelAberrant promoter CpG methylation and its translational applications in breast cancer.
P2860
Q21260388-9549EB0F-43A3-457D-8AAA-6F4858642D44Q21558626-AF85B1B0-5330-48E2-AA16-DEC4ABA1EFA0Q24792846-F36B2150-F3CD-4359-91D4-CEF76F4C8DC8Q25257315-499ACF30-61EC-4D41-80E4-3E8384B1BE5DQ26738987-589B0F50-2139-481C-990C-56D0D56E3C0AQ26740086-BE9A5660-1104-493D-94BE-B5B903F15809Q26860821-685A3FD8-377E-4EBA-8BDB-41EB1E9717C8Q27437626-CB67CBDB-F9A5-4CD0-BC63-7DD91F7F7412Q28386334-B780AFF8-75D0-4995-9D96-118D152E5666Q30506064-C26DA1EC-805E-4BD0-AE6D-7BE5CF00E28AQ30979173-A4DFF370-C578-4C67-82E7-5E22E8230621Q33540332-CD349EDF-3E90-46E5-BB7B-3F08ED84E5C3Q33556583-6C8564F7-425C-4113-ACA2-F0FAEB222DCBQ33739319-DB829062-7F47-4542-A8B2-814AAB860192Q33807653-34871B3D-62D9-411A-9C1B-0293C331AFE9Q33972805-F4179825-9D81-4C97-AF97-28806ADAA13CQ34061919-E786C0AE-1206-49B0-AF23-A14DD0E6097CQ34183409-A24B616F-12CA-4385-B275-D4CA780869C3Q34360642-A100B078-6868-4855-B86C-78F177EC6A32Q34613461-41916FD1-482A-4E67-8D84-5A8262D949D4Q35050475-95D49D1C-BBC2-4D10-ADCC-30D58FB1C328Q35179788-4C813AA3-9629-4B45-B0A7-25CA9CC5941AQ35552256-B7B4131B-E007-4C54-A92A-859C174D9861Q35591546-D9872F61-A8BF-4115-9431-E3DE7646B9CAQ35633512-B900B8D0-2237-494C-8D4B-E1012D6F9D58Q35636561-2E5E7869-563F-4D87-829A-DCEAE4FE2120Q35686593-C4FE41ED-CCB6-4C0A-BDDE-95D3BD1B1C22Q35788734-9F23C703-53F9-4557-803A-64FBD055EA9EQ35970193-C417DEB5-622D-4DDF-B5B6-57BAAAD4F224Q36091457-3946F45D-9775-4ADA-A5AC-92AE5B6E3840Q36477008-93B94010-1C82-49A7-ABBE-BB4B34392BF8Q36600205-F21BE366-5BAC-402D-897D-0E3E4B8E456EQ36787353-464990CA-9A1A-42A9-A72D-5F3EAAE749A9Q36837622-0DE0F99B-229F-4BD1-85C0-25B83D3B95F0Q36856318-95021E11-8C03-41AD-A9D6-CDE3AD57634DQ36924384-0738CB26-6B35-4B61-B589-9D38F55243CBQ36977572-610F3DB8-A564-4E34-84F6-9AA123997242Q37078784-4BED480F-3C69-4129-A8FF-40076780E61EQ37148677-C494683B-5A86-4002-9453-664842EEDBD0Q37354053-F2D35AD0-99C6-4C89-BDC4-E4EDD177FD5E
P2860
Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Aberrant methylation of the ad ...... in breast and lung carcinomas.
@en
Aberrant methylation of the adenomatous polyposis coli
@nl
type
label
Aberrant methylation of the ad ...... in breast and lung carcinomas.
@en
Aberrant methylation of the adenomatous polyposis coli
@nl
prefLabel
Aberrant methylation of the ad ...... in breast and lung carcinomas.
@en
Aberrant methylation of the adenomatous polyposis coli
@nl
P2093
P1476
Aberrant methylation of the ad ...... in breast and lung carcinomas.
@en
P2093
Cunnigham HT
Farinas AJ
Gilcrease M
Milchgrub S
P304
P407
P577
2001-07-01T00:00:00Z